Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 1.000 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.577 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.522 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.512 | |
| 2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.502 | |
| 1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.496 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.496 | |
| 2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.495 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.495 | |
| 4bie | IE6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.495 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.494 | |
| 3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.492 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.492 | |
| 2pvh | P19 | Casein kinase II subunit alpha | 2.7.11.1 | 0.491 | |
| 4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.489 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.489 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.488 | |
| 1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.485 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.485 | |
| 5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.485 | |
| 4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.484 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.483 | |
| 1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.482 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.482 | |
| 4r8q | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.482 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.481 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.481 | |
| 4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.481 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.480 | |
| 4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.479 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.478 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.477 | |
| 4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.477 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.476 | |
| 2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.475 | |
| 4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.474 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.473 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.473 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.473 | |
| 1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.472 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.472 | |
| 4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.472 | |
| 4idv | 13V | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.472 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.472 | |
| 4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.471 | |
| 2dwb | ANP | Aurora kinase A | 2.7.11.1 | 0.470 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.470 | |
| 1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.469 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.469 | |
| 2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.469 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.469 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.468 | |
| 3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.468 | |
| 4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.468 | |
| 1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.467 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.467 | |
| 2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.465 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.465 | |
| 2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.464 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.464 | |
| 4gub | 0Y4 | Casein kinase II subunit alpha | 2.7.11.1 | 0.464 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.463 | |
| 2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.463 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
| 5dr6 | SKE | Aurora kinase A | 2.7.11.1 | 0.463 | |
| 1bxo | PP7 | Penicillopepsin-1 | 3.4.23.20 | 0.462 | |
| 1daw | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.462 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.462 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.462 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.461 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.461 | |
| 2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.460 | |
| 3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.460 | |
| 4idt | T28 | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.460 | |
| 1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
| 2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.459 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.459 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.459 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.459 | |
| 4im2 | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.459 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
| 5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.459 | |
| 1e9h | INR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.457 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.457 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.457 | |
| 4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.457 | |
| 5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.457 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.456 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.456 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.456 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.456 | |
| 4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.456 | |
| 1uv5 | BRW | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.455 | |
| 4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
| 3m42 | HGF | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.454 | |
| 4i0s | 1B5 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.454 | |
| 4wuo | NAD | 3-isopropylmalate dehydrogenase | 1.1.1.85 | 0.454 | |
| 1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 1hii | C20 | Gag-Pol polyprotein | / | 0.453 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
| 5dpv | SKE | Aurora kinase A | 2.7.11.1 | 0.453 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.452 | |
| 2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.452 | |
| 3lfn | A27 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.452 | |
| 4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.452 | |
| 5dt3 | ATP | Aurora kinase A | 2.7.11.1 | 0.452 | |
| 1ol7 | ADP | Aurora kinase A | 2.7.11.1 | 0.451 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
| 2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 2e9v | 85A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.451 | |
| 4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.451 | |
| 4dgm | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
| 4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.451 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.450 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.450 | |
| 3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.450 | |
| 4jaj | XU1 | Aurora kinase A | 2.7.11.1 | 0.450 | |
| 5dmz | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.450 | |
| 2cke | IQU | Death-associated protein kinase 2 | / | 0.449 | |
| 2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
| 3inm | NDP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.449 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.449 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.449 | |
| 5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.449 | |
| 1idb | 0DO | Gag-Pol polyprotein | / | 0.448 | |
| 1ke6 | LS2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
| 2wec | PP5 | Penicillopepsin-1 | 3.4.23.20 | 0.448 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
| 4dn5 | AGS | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.448 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.448 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.448 | |
| 1bxq | PP8 | Penicillopepsin-1 | 3.4.23.20 | 0.447 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.447 | |
| 2rio | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.447 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.447 | |
| 2xne | ASH | Aurora kinase A | 2.7.11.1 | 0.447 | |
| 3gu8 | 3GU | Death-associated protein kinase 1 | 2.7.11.1 | 0.447 | |
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 3oro | AGS | Serine/threonine protein kinase | / | 0.447 | |
| 3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
| 3tqh | NDP | Quinone oxidoreductase | / | 0.447 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.447 | |
| 3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
| 4acg | 6LQ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.447 | |
| 4qpm | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.447 | |
| 1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.446 | |
| 2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.446 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.446 | |
| 3och | 2MX | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
| 4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.446 | |
| 4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.446 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.446 | |
| 1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.445 | |
| 3dog | NNN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.445 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.445 | |
| 4fyo | 0VF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.445 | |
| 2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
| 3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
| 3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.444 | |
| 4iwq | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.444 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.444 | |
| 4kzo | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.444 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.444 | |
| 1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 1ke7 | LS3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 1ppm | 0P1 | Penicillopepsin-1 | 3.4.23.20 | 0.443 | |
| 2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.443 | |
| 2uze | C95 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.443 | |
| 3f46 | I2C | 5,10-methenyltetrahydromethanopterin hydrogenase | 1.12.98.2 | 0.443 | |
| 3u9e | COA | Lmo1369 protein | / | 0.443 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.443 | |
| 4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.443 | |
| 4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.443 | |
| 4ewh | T77 | Activated CDC42 kinase 1 | / | 0.443 | |
| 1lp4 | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
| 2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.442 | |
| 2np8 | CC3 | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 2pmo | HMD | Protein kinase 7 | / | 0.442 | |
| 2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.442 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.442 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
| 2eva | ADN | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.441 | |
| 2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 3icr | COA | Coenzyme A disulfide reductase | / | 0.441 | |
| 3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 4o0s | ADN | Aurora kinase A | 2.7.11.1 | 0.441 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.441 | |
| 5dn3 | ATP | Aurora kinase A | 2.7.11.1 | 0.441 | |
| 1m2q | MNX | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 | |
| 2e9p | 77A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.440 | |
| 2qfx | NDP | Isocitrate dehydrogenase [NADP], mitochondrial | 1.1.1.42 | 0.440 | |
| 3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 |